Newborn of mothers affected by autoimmune thyroiditis: the importance of thyroid function monitoring in the first months of life
Authors:
- Rosanna RovelliRRRosanna Rovelli
- Maria Cristina VigoneMVMaria Cristina Vigone
- Chiara GiovanettoniCGChiara Giovanettoni
- Arianna PassoniAPArianna Passoni
- Ludovica MainaLMLudovica Maina
- Andrea CorriasACAndrea Corrias
- Carlo CorbettaCCCarlo Corbetta
- Fabio MoscaFMFabio Mosca
- Giuseppe ChiumelloGCGiuseppe Chiumello
- Giovanna WeberGWGiovanna Weber
Open Access
- 10 March 2010
- journal article
- case report
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 36 (1) , 24
Abstract
Background: evaluation of thyroid function in neonates born from mothers affected by autoimmune thyroiditis in order to define if a precise follow-up is necessary for these children. The influence of maternal thyroid peroxidase antibody (TPOAb) and L-thyroxine therapy during pregnancy on neonatal thyroid function was also investigated. Methods: 129 neonates were tested for thyroid function by measurement of free thyroxine (FT4) and thyroid stimulating hormone (TSH) in 3th day, 15th day and at one month of life. TPOAb were measured in all patients; periodical control of thyroid function were performed until 6 months of life if Ab were positive. Data concerning etiology of maternal hypothyroidism and maternal replacement therapy with L-thyroxine during pregnancy were retrospectively collected. Results: 28% neonates showed at least a mild increase of TSH value at the different determinations. In the majority of them, a spontaneous completely normalisation of TSH value was observed within the first month life. L-thyroxine replacement therapy was started in 3 neonates. TPOAb titer and maternal L-thyroxine replacement therapy were not related to alteration of thyroid hormone function in our study population. Conclusions: transient mild elevation of serum TSH above the normal reference value for age is frequently observed in the first month of life in infants born from mothers affected by autoimmune thyroiditis. Persistent hyperthyrotropinemia requiring replacement therapy is observed in 2.2% of these neonates. According to our experience, follow-up is recommended in these newborns; the most accurate and not invasive way to carefully monitor these infants after neonatal screening for CH seems to be serum-testing TSH between 2ndand 4th week of life.Keywords
This publication has 20 references indexed in Scilit:
- Transient Neonatal Hypothyroidism is Associated with Elevated Serum Anti-Thyroglobulin Antibody Levels in Newborns and Their MothersThe Journal of Pediatrics, 2007
- Update of Newborn Screening and Therapy for Congenital HypothyroidismPediatrics, 2006
- Are Detection and Treatment of Thyroid Insufficiency in Pregnancy Feasible?Thyroid®, 2005
- Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with HypothyroidismNew England Journal of Medicine, 2004
- Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the ChildNew England Journal of Medicine, 1999
- Thyroid function in mothers of hypothyroid newbornsObstetrics & Gynecology, 1999
- Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babiesThe Journal of Clinical Endocrinology & Metabolism, 1996
- Prevalence of thyroid deficiency in pregnant womenClinical Endocrinology, 1991
- Maternal-Fetal Transfer of Thyroxine in Congenital Hypothyroidism Due to a Total Organification Defect or Thyroid AgenesisNew England Journal of Medicine, 1989
- Lack of influence of thyroid antibodies on thyroid function in the newborn infant and on a mass screening program for congenital hypothyroidismThe Journal of Pediatrics, 1980